SI
INBX icon

Sofinnova Investments’s Inhibrx INBX Stock Holding History

Sofinnova Investments’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.7M Sell
303,103
-102,926
-25% -$10.3M 1.48% 25
2026
Q1 		$27.3M Sell
406,029
-48,628
-11% -$3.61M 1.04% 33
2025
Q4 		$35.9M Buy
454,657
+14,565
+3% +$992K 1.55% 21
2025
Q3 		$14.8M Sell
440,092
-268,586
-38% -$6.61M 0.81% 37
2025
Q2 		$10.1M Buy
708,678
+10,762
+2% +$139K 0.62% 41
2025
Q1 		$9.76M Buy
697,916
+170,726
+32% +$2.32M 0.64% 37
2024
Q4 		$8.12M Sell
527,190
-8,878
-2% -$135K 0.59% 37
2024
Q3 		$8.39M Buy
536,068
+72,753
+16% +$1.02M 0.67% 32
2024
Q2 		$6.57M Buy
+463,315
New +$7.24M 0.34% 51

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sofinnova Investments's INBX Position: Q2 2026 in Review

Sofinnova Investments reduced its Inhibrx (INBX) stake by 25% in Q2 2026, selling an estimated $10.3M and leaving 303,103 shares worth $28.7M. The position accounts for 1.48% of the portfolio, ranked #25.

Sofinnova Investments first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $35.9M in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Sofinnova Investments held 303,103 shares of Inhibrx worth $28.7M as of Q2 2026.
  • Sofinnova Investments sold 102,926 Inhibrx shares in Q2 2026, an estimated $10.3M.
  • Inhibrx made up 1.48% of Sofinnova Investments's portfolio in Q2 2026, its #25 holding.
  • Sofinnova Investments first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • Sofinnova Investments's Inhibrx position peaked at $35.9M in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.